The Full Wiki

More info on Ofatumumab

Ofatumumab: Quiz

Advertisements
  

Question 1: Ofatumumab targets an epitope different from ________ and most other anti-CD20 antibodies.
BevacizumabTrastuzumabRituximabCetuximab

Question 2: lymphoid: ________ (Ibritumomab, Ofatumumab, Rituximab, Tositumomab), CD52 (Alemtuzumab)
CD4CD11cCD20CD14

Question 3: ________ – Phase III
B-cell chronic lymphocytic leukemiaHairy cell leukemiaHodgkin's lymphomaAcute lymphoblastic leukemia

Question 4: On January 30, 2009, ________ submitted a Biologics License Application to the FDA to use Ofatumumab to treat cases of CLL.
GenmabJyske BankDaniscoDanske Bank

Question 5: The drug is also known as HuMax-CD20) is a human monoclonal antibody (for the ________ protein) which appears to inhibit early-stage B lymphocyte activation.
CD14CD11cCD20CD4







Advertisements









Got something to say? Make a comment.
Your name
Your email address
Message